139 related articles for article (PubMed ID: 33356698)
1. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.
Jensen JS; Jakobsen KK; Mirian C; Ghanizada M; Håkansson K; Wessel I; Grønhøj C; Rasmussen JH; von Buchwald C
Acta Oncol; 2021 Apr; 60(4):491-496. PubMed ID: 33356698
[TBL] [Abstract][Full Text] [Related]
2. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
3. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.
Balchander D; Shorbaji K; Cabrera CI; Hoying D; Clancy K; Fowler N; Thuener JE; Lavertu P; Pan Q; Teknos TN; Rezaee RP; Li S; Tamaki A
Am J Otolaryngol; 2023; 44(6):103966. PubMed ID: 37481899
[TBL] [Abstract][Full Text] [Related]
5. No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013.
Kouka M; Engelhardt M; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4549-4560. PubMed ID: 35488907
[TBL] [Abstract][Full Text] [Related]
6. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
7. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
8. The impact of tobacco smoking on survival of patients with oral squamous cell carcinoma: a population-based retrospective study.
Andersen AO; Jensen JS; Jakobsen KK; Stampe H; Nielsen KJ; Wessel I; Christensen A; Andersen E; Friborg J; Grønhøj C; von Buchwald C
Acta Oncol; 2022 Apr; 61(4):449-458. PubMed ID: 35114883
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.
Sheni R; Qin J; Viswanathan S; Castellucci E; Kalnicki S; Mehta V
JCO Oncol Pract; 2023 Jun; 19(6):e904-e915. PubMed ID: 37001038
[TBL] [Abstract][Full Text] [Related]
10. The impact of comorbidities on survival in oral cancer patients: a population-based, case-control study.
Ghanizada M; Jakobsen KK; Jensen JS; Wessel I; Filtenborg Tvedskov J; Grønhøj C; von Buchwald C
Acta Oncol; 2021 Feb; 60(2):173-179. PubMed ID: 33103528
[TBL] [Abstract][Full Text] [Related]
11. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.
Grønhøj C; Jensen D; Dehlendorff C; Nørregaard C; Andersen E; Specht L; Charabi B; von Buchwald C
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):375-381. PubMed ID: 29526405
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.
Chen JJ; Shah JL; Harris JP; Bui TT; Schaberg K; Kong CS; Kaplan MJ; Divi V; Schoppy D; Le QT; Hara WY
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):775-783. PubMed ID: 28602409
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
[TBL] [Abstract][Full Text] [Related]
14. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors in patients with oral squamous cell carcinoma.
Ferreira AK; Carvalho SH; Granville-Garcia AF; Sarmento DJ; Agripino GG; Abreu MH; Melo MC; Caldas AD; Godoy GP
Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e387-e392. PubMed ID: 33037796
[TBL] [Abstract][Full Text] [Related]
16. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
Zhao TC; Liang SY; Ju WT; Liu Y; Tan YR; Zhu DW; Zhang CP; Zhang ZY; Zhong LP
Clin Nutr; 2020 Sep; 39(9):2751-2758. PubMed ID: 31839432
[TBL] [Abstract][Full Text] [Related]
17. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
Liao CT; Chen HN; Wen YW; Lee SR; Ng SH; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Wang CP; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC
Eur J Cancer; 2017 Feb; 72():226-234. PubMed ID: 28056426
[TBL] [Abstract][Full Text] [Related]
18. Validation of the UICC 8th edition staging of oral cavity squamous cell carcinoma in a UK cohort.
McGoldrick DM; Torres-Rendon A; Sandhu R; Walton G
Br J Oral Maxillofac Surg; 2021 Jan; 59(1):76-81. PubMed ID: 33082012
[TBL] [Abstract][Full Text] [Related]
19. Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database.
Desai AD; Behbahani S; Samie FH
Clin Exp Dermatol; 2022 Jul; 47(7):1275-1282. PubMed ID: 35150153
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
